CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-06-05 | MATTINGLY MARTIN A Director | Option exercise | +2,500 | 5,500 | ||
| 2014-06-05 | MATTINGLY MARTIN A Director | Option exercise · Restricted Stock Unit (RSU) | −2,500 | 0 | ||
| 2014-06-05 | MATTINGLY MARTIN A Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2014-06-05 | MATTINGLY MARTIN A Director | Grant or award · Restricted Stock Unit (RSU) | +2,500 | 2,500 | ||
| 2014-06-05 | GOLDSTEIN JACK Director | Option exercise | +4,500 | 7,500 | ||
| 2014-06-05 | GOLDSTEIN JACK Director | Option exercise · Restricted Stock Unit (RSU) | −4,500 | 0 | ||
| 2014-06-05 | GOLDSTEIN JACK Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2014-06-05 | GOLDSTEIN JACK Director | Grant or award · Restricted Stock Unit (RSU) | +5,000 | 5,000 | ||
| 2014-06-05 | Clendeninn Neil James Director | Option exercise | +2,500 | 12,062 | ||
| 2014-06-05 | Clendeninn Neil James Director | Option exercise · Restricted Stock Unit (RSU) | −2,500 | 0 | ||
| 2014-06-05 | Clendeninn Neil James Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2014-06-05 | Clendeninn Neil James Director | Grant or award · Restricted Stock Unit (RSU) | +2,500 | 2,500 | ||
| 2014-03-17 | Wyrick Susan D. PAO | Sale | −182 | $12.25 | $2K | 1,312 |
| 2014-03-17 | JACOBS CINDY EVP, CMO | Sale | −1,250 | $12.25 | $15K | 28,905 |
| 2014-03-17 | Cormack Scott Daniel President and CEO | Sale | −4,634 | $12.25 | $57K | 64,980 |
| 2014-03-14 | Wyrick Susan D. PAO | Option exercise | +516 | 1,494 | ||
| 2014-03-14 | Wyrick Susan D. PAO | Option exercise · Restricted Stock Unit (RSU) | −516 | 1,547 | ||
| 2014-03-14 | Wyrick Susan D. PAO | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2014-03-14 | Wyrick Susan D. PAO | Grant or award · Restricted Stock Unit (RSU) | +5,000 | 5,000 | ||
| 2014-03-14 | Wyrick Susan D. PAO | Grant or award · Restricted Stock Unit (RSU) | +10,000 | 10,000 |
Page 28 of 36 · 715 trades